---
figid: PMC9336077__12935_2022_2660_Fig2_HTML
figtitle: Molecular biology and therapeutic potential of Nrf2 in leukemia
organisms:
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
- Caenorhabditis elegans
- Homo sapiens
- Gallus gallus
- Helicobacter pylori
- Cinnamomum verum
pmcid: PMC9336077
filename: 12935_2022_2660_Fig2_HTML.jpg
figlink: /pmc/articles/PMC9336077/figure/Fig2/
number: F2
caption: Nrf2 signaling pathway in the malignant cells. In normal conditions, three
  E3 ubiquitin ligases suppress Nrf2 by forming an inhibitory complex (Keap1-CUL3-RBX1,
  β-TrCP-SKP1-CUL1-RBX1, and HRD1). However, in leukemic cells or under oxidative
  stress, Nrf2 is released from this negative regulator and activates the transcription
  of target genes after forming heterodimers with sMAF. Moreover, Nurse-like cells
  produce Baff in the malignant cell microenvironment that induces ROR1 and Baff receptor
  expression on the malignant cells, leading to an inflammatory cytokine (NF-κB, IL6,
  TNF) increase inside the leukemic cells and recruitment of P65p, which binds to
  Keap1, and releases Nrf2 from the Keap1-CUL3-RBX1 inhibitory complex
papertitle: The molecular biology and therapeutic potential of Nrf2 in leukemia.
reftext: Atefeh Khodakarami, et al. Cancer Cell Int. 2022;22:241.
year: '2022'
doi: 10.1186/s12935-022-02660-5
journal_title: Cancer Cell International
journal_nlm_ta: Cancer Cell Int
publisher_name: BioMed Central
keywords: Leukemia | Transcription factor | Nrf2 | Chemotherapy
automl_pathway: 0.9560956
figid_alias: PMC9336077__F2
figtype: Figure
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Gallus gallus
- Drosophila melanogaster
- Caenorhabditis elegans
redirect_from: /figures/PMC9336077__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9336077__12935_2022_2660_Fig2_HTML.html
  '@type': Dataset
  description: Nrf2 signaling pathway in the malignant cells. In normal conditions,
    three E3 ubiquitin ligases suppress Nrf2 by forming an inhibitory complex (Keap1-CUL3-RBX1,
    β-TrCP-SKP1-CUL1-RBX1, and HRD1). However, in leukemic cells or under oxidative
    stress, Nrf2 is released from this negative regulator and activates the transcription
    of target genes after forming heterodimers with sMAF. Moreover, Nurse-like cells
    produce Baff in the malignant cell microenvironment that induces ROR1 and Baff
    receptor expression on the malignant cells, leading to an inflammatory cytokine
    (NF-κB, IL6, TNF) increase inside the leukemic cells and recruitment of P65p,
    which binds to Keap1, and releases Nrf2 from the Keap1-CUL3-RBX1 inhibitory complex
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Nfe2l2
  - Il6
  - Tnf
  - Nfkb1
  - Tnfsf13b
  - Btrc
  - Keap1
  - Cul3
  - Rbx1
  - Syvn1
  - Gtf2h1
  - Nup62
  - Sqstm1
  - Khdrbs1
  - Dctn4
  - Alpha-re
  - Eif2ak3
  - Lamp1
  - Mak
  - Alpk3
  - Ephb2
  - Mapk1
  - Ror1
  - Rora
  - Bach1
  - Brip1
  - Eif2ak2
  - Gsk3b
  - Pik3r1
  - Skp1
  - Notch1
  - Ephb1
  - Pik3cg
  - GABPA
  - NFE2L2
  - IL6
  - TNF
  - NFKB1
  - TNFSF13B
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - BTRC
  - KEAP1
  - CUL3
  - RBX1
  - SYVN1
  - GTF2H1
  - SQSTM1
  - KHDRBS1
  - NUP62
  - DCTN4
  - EIF2AK3
  - SGSM3
  - MAK
  - ALPK3
  - EPHB2
  - MAPK1
  - MAPK3
  - ROR1
  - RORA
  - BACH1
  - BRIP1
  - EIF2AK2
  - GSK3B
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - SKP1
  - LITAF
  - GSK3A
  - cnc
  - egr
  - Dif
  - dl
  - Rel
  - .na.character
  - slmb
  - Roc1a
  - sip3
  - ref(2)P
  - DCTN4-p62
  - Tfb1
  - Taf6
  - how
  - PEK
  - rl
  - maf-S
  - mapP
  - CG42366
  - mle
  - E(spl)malpha-BFM
  - Erk7
  - Ror
  - sgg
  - Axn
  - gskt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - SkpA
  - cul-3
  - rbx-1
  - skp-1
---
